We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PBH market cap is 4.27B. The company's latest EPS is USD 4.2258 and P/E is 20.40.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 282.74M | 276.99M | 267.14M | 283.79M | 290.32M |
| Operating Income | 86.83M | 82.15M | 72.05M | 84.34M | 91.96M |
| Net Income | 53.05M | 49.46M | 49.07M | 54.38M | 61.03M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 963.01M | 943.37M | 1.09B | 1.13B | 1.13B |
| Operating Income | 291.16M | 297.4M | 329.92M | -22.42M | 342.43M |
| Net Income | 142.28M | 164.68M | 205.38M | -82.31M | 209.34M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.34B | 3.32B | 3.31B | 3.32B | 3.33B |
| Total Liabilities | 1.74B | 1.66B | 1.63B | 1.59B | 1.54B |
| Total Equity | 1.6B | 1.66B | 1.68B | 1.73B | 1.79B |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.51B | 3.43B | 3.67B | 3.35B | 3.32B |
| Total Liabilities | 2.34B | 2.07B | 2.09B | 1.91B | 1.66B |
| Total Equity | 1.17B | 1.36B | 1.58B | 1.45B | 1.66B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 182.02M | 248.93M | 54.78M | 124.58M | 189.67M |
| Investing | -5.11M | -20.11M | -2.13M | -4.16M | -13.97M |
| Financing | -172.57M | -241.02M | -65.52M | -116.72M | -170.59M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 217.12M | 235.61M | 259.92M | 229.72M | 248.93M |
| Investing | -16.57M | -22.24M | -256.51M | -11.58M | -20.11M |
| Financing | -131.43M | -279.42M | -7.57M | -185.85M | -241.02M |
| Market Cap | 4.27B |
| Price to Earnings Ratio | 20.40 |
| Price to Sales Ratio | 3.79 |
| Price to Cash Ratio | 91.9 |
| Price to Book Ratio | 2.58 |
| Dividend Yield | - |
| Shares Outstanding | 49.54M |
| Average Volume (1 week) | 266.7k |
| Average Volume (1 Month) | 340.33k |
| 52 Week Change | 23.03% |
| 52 Week High | 88.36 |
| 52 Week Low | 62.35 |
| Spread (Intraday) | 3.01 (3.42%) |
| Company Name | Prestige Consumer Healthcare Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.prestigebrands.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
